共 50 条
- [42] Rituxan delays disease progression in indolent non-Hodgkin's lymphoma ONCOLOGY-NEW YORK, 2002, 16 (11): : 1472 - 1472
- [46] Optimizing the clinical benefit of rituximab - in indolent non-Hodgkin's lymphoma CLINICAL LYMPHOMA, 2004, 5 (03): : 149 - 151
- [49] Considerations with newer regimens for indolent non-Hodgkin lymphoma CLINICAL LYMPHOMA & MYELOMA, 2008, 8 : S128 - S136
- [50] Radiotherapy indications in non-Hodgkin lymphoma CANCER RADIOTHERAPIE, 2009, 13 (6-7): : 471 - 478